Fréquence critique de fusion : Questions médicales fréquentes
Nom anglais: Flicker Fusion
Descriptor UI:D005425
Tree Number:G14.370
Termes MeSH sélectionnés :
Prostatic Neoplasms
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Fréquence critique de fusion : Questions médicales les plus fréquentes",
"headline": "Fréquence critique de fusion : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Fréquence critique de fusion : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-05",
"dateModified": "2025-02-28",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Fréquence critique de fusion"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Phénomènes physiologiques oculaires",
"url": "https://questionsmedicales.fr/mesh/D009799",
"about": {
"@type": "MedicalCondition",
"name": "Phénomènes physiologiques oculaires",
"code": {
"@type": "MedicalCode",
"code": "D009799",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Fréquence critique de fusion",
"alternateName": "Flicker Fusion",
"code": {
"@type": "MedicalCode",
"code": "D005425",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Natalia D Mankowska",
"url": "https://questionsmedicales.fr/author/Natalia%20D%20Mankowska",
"affiliation": {
"@type": "Organization",
"name": "Applied Cognitive Neuroscience Lab, Department of Human Physiology, Medical University of Gdansk, 80-210 Gdansk, Poland."
}
},
{
"@type": "Person",
"name": "Anna B Marcinkowska",
"url": "https://questionsmedicales.fr/author/Anna%20B%20Marcinkowska",
"affiliation": {
"@type": "Organization",
"name": "Applied Cognitive Neuroscience Lab, Department of Human Physiology, Medical University of Gdansk, 80-210 Gdansk, Poland."
}
},
{
"@type": "Person",
"name": "Pawel J Winklewski",
"url": "https://questionsmedicales.fr/author/Pawel%20J%20Winklewski",
"affiliation": {
"@type": "Organization",
"name": "2nd Department of Radiology, Medical University of Gdansk, 80-210 Gdansk, Poland."
}
},
{
"@type": "Person",
"name": "Rita I Sharma",
"url": "https://questionsmedicales.fr/author/Rita%20I%20Sharma",
"affiliation": {
"@type": "Organization",
"name": "Department of Human Physiology, Medical University of Gdansk, 80-210 Gdansk, Poland."
}
},
{
"@type": "Person",
"name": "Jacek Kot",
"url": "https://questionsmedicales.fr/author/Jacek%20Kot",
"affiliation": {
"@type": "Organization",
"name": "National Centre for Hyperbaric Medicine, Institute of Maritime and Tropical Medicine in Gdynia, Medical University of Gdansk, 80-210 Gdansk, Poland."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Prostate and metastasis-directed focal therapy in prostate cancer: hype or hope?",
"datePublished": "2023-02-03",
"url": "https://questionsmedicales.fr/article/36718727",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/14737140.2023.2171991"
}
},
{
"@type": "ScholarlyArticle",
"name": "The combined role of MRI prostate and prostate health index in improving detection of significant prostate cancer in a screening population of Chinese men.",
"datePublished": "2023-05-02",
"url": "https://questionsmedicales.fr/article/37534902",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4103/aja20239"
}
},
{
"@type": "ScholarlyArticle",
"name": "Simultaneous thulium laser resection of the prostate and transperineal prostate biopsy in clinically diagnosed metastatic prostate cancer with bladder outlet obstruction.",
"datePublished": "2023-08-18",
"url": "https://questionsmedicales.fr/article/37596454",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10103-023-03848-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Staging Prostate Cancer with",
"datePublished": "2023-04-28",
"url": "https://questionsmedicales.fr/article/37116912",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2967/jnumed.122.265371"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prostate MRI Qualification:",
"datePublished": "2022-05-11",
"url": "https://questionsmedicales.fr/article/35544372",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2214/AJR.22.27615"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes physiologiques oculaires",
"item": "https://questionsmedicales.fr/mesh/D009799"
},
{
"@type": "ListItem",
"position": 3,
"name": "Fréquence critique de fusion",
"item": "https://questionsmedicales.fr/mesh/D005425"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Fréquence critique de fusion - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Fréquence critique de fusion",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Fréquence critique de fusion",
"description": "Comment évaluer la fréquence critique de fusion ?\nQuels outils sont utilisés pour le diagnostic ?\nQuels sont les critères de diagnostic ?\nPeut-on diagnostiquer des troubles avec ce test ?\nQuel professionnel effectue ce diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D005425?mesh_terms=Prostatic+Neoplasms&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Fréquence critique de fusion",
"description": "Quels symptômes indiquent un problème de fusion ?\nLa sensibilité à la lumière est-elle un symptôme ?\nPeut-on ressentir des vertiges ?\nLes troubles de la vision sont-ils fréquents ?\nY a-t-il des signes de fatigue visuelle ?",
"url": "https://questionsmedicales.fr/mesh/D005425?mesh_terms=Prostatic+Neoplasms&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Fréquence critique de fusion",
"description": "Comment prévenir les problèmes de fusion ?\nL'éclairage ambiant joue-t-il un rôle ?\nDes pauses régulières sont-elles nécessaires ?\nL'hydratation aide-t-elle à la prévention ?\nLes examens réguliers sont-ils importants ?",
"url": "https://questionsmedicales.fr/mesh/D005425?mesh_terms=Prostatic+Neoplasms&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Fréquence critique de fusion",
"description": "Quels traitements sont disponibles pour ce problème ?\nLa thérapie comportementale aide-t-elle ?\nDes médicaments sont-ils prescrits ?\nLes exercices oculaires sont-ils efficaces ?\nQuand consulter un spécialiste ?",
"url": "https://questionsmedicales.fr/mesh/D005425?mesh_terms=Prostatic+Neoplasms&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Fréquence critique de fusion",
"description": "Quelles complications peuvent survenir ?\nLes troubles neurologiques sont-ils possibles ?\nPeut-on développer une anxiété liée à la vision ?\nDes problèmes de coordination peuvent-ils survenir ?\nLes troubles de l'humeur sont-ils liés ?",
"url": "https://questionsmedicales.fr/mesh/D005425?mesh_terms=Prostatic+Neoplasms&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Fréquence critique de fusion",
"description": "Quels sont les facteurs de risque principaux ?\nL'âge influence-t-il la fréquence critique de fusion ?\nLes troubles oculaires augmentent-ils le risque ?\nLe stress a-t-il un impact ?\nLes antécédents familiaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D005425?mesh_terms=Prostatic+Neoplasms&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer la fréquence critique de fusion ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests visuels mesurant la perception de clignotement sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels outils sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des appareils comme les photomètres et les dispositifs de stimulation lumineuse sont employés."
}
},
{
"@type": "Question",
"name": "Quels sont les critères de diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "La mesure de la fréquence à laquelle le clignotement est perçu comme continu."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer des troubles avec ce test ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles neurologiques ou visuels peuvent être identifiés."
}
},
{
"@type": "Question",
"name": "Quel professionnel effectue ce diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un ophtalmologiste ou un spécialiste de la vision réalise ces tests."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème de fusion ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des maux de tête, fatigue oculaire ou difficulté à percevoir des mouvements peuvent survenir."
}
},
{
"@type": "Question",
"name": "La sensibilité à la lumière est-elle un symptôme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une sensibilité accrue à la lumière peut être liée à des problèmes de fusion."
}
},
{
"@type": "Question",
"name": "Peut-on ressentir des vertiges ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des vertiges peuvent survenir en raison de la perception altérée des lumières."
}
},
{
"@type": "Question",
"name": "Les troubles de la vision sont-ils fréquents ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles comme la vision floue peuvent être associés à des problèmes de fusion."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes de fatigue visuelle ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une fatigue visuelle peut se manifester par des difficultés à se concentrer sur des lumières clignotantes."
}
},
{
"@type": "Question",
"name": "Comment prévenir les problèmes de fusion ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter une exposition prolongée à des lumières clignotantes et faire des pauses régulières."
}
},
{
"@type": "Question",
"name": "L'éclairage ambiant joue-t-il un rôle ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un éclairage adéquat peut réduire la fatigue oculaire et les problèmes de fusion."
}
},
{
"@type": "Question",
"name": "Des pauses régulières sont-elles nécessaires ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, faire des pauses fréquentes lors de l'utilisation d'écrans est recommandé."
}
},
{
"@type": "Question",
"name": "L'hydratation aide-t-elle à la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une bonne hydratation peut contribuer à la santé oculaire générale."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils importants ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers chez un ophtalmologiste aident à détecter précocement les problèmes."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour ce problème ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des lunettes correctrices ou des thérapies visuelles peuvent être recommandées."
}
},
{
"@type": "Question",
"name": "La thérapie comportementale aide-t-elle ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la thérapie comportementale peut aider à gérer les symptômes associés."
}
},
{
"@type": "Question",
"name": "Des médicaments sont-ils prescrits ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments peuvent être prescrits pour traiter des troubles sous-jacents."
}
},
{
"@type": "Question",
"name": "Les exercices oculaires sont-ils efficaces ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des exercices oculaires peuvent améliorer la perception visuelle et réduire la fatigue."
}
},
{
"@type": "Question",
"name": "Quand consulter un spécialiste ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est conseillé de consulter si des symptômes persistent ou s'aggravent."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des migraines ou des troubles de la concentration peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les troubles neurologiques sont-ils possibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles neurologiques peuvent être exacerbés par des problèmes de fusion."
}
},
{
"@type": "Question",
"name": "Peut-on développer une anxiété liée à la vision ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'anxiété peut survenir en raison de la difficulté à traiter les stimuli visuels."
}
},
{
"@type": "Question",
"name": "Des problèmes de coordination peuvent-ils survenir ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des problèmes de coordination visuelle peuvent être une complication."
}
},
{
"@type": "Question",
"name": "Les troubles de l'humeur sont-ils liés ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles de l'humeur peuvent être associés à des problèmes de perception visuelle."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque principaux ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exposition prolongée à des écrans et des lumières vives augmente le risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il la fréquence critique de fusion ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut affecter la perception visuelle et la fréquence critique."
}
},
{
"@type": "Question",
"name": "Les troubles oculaires augmentent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles comme la myopie ou l'astigmatisme peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut exacerber les problèmes de perception visuelle et de fusion."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de troubles visuels peuvent augmenter le risque."
}
}
]
}
]
}
The paradigm of focal therapy's role in metastatic patients is being challenged by evolving attitudes and emerging data. At the current time, specifically regarding prostate cancer, does the evidence ...
We searched the literature via PubMed, MEDLINE, and Embase for studies from 2014 to the present addressing focal therapy with non-palliative intent in metastatic prostate cancer patients, emphasizing ...
Current evidence is strongest, and in our opinion practice-changing, for prostate-directed RT in de novo metastatic patients with low metastatic burden. Metastasis-directed therapy with SBRT is consis...
Using prostate-specific antigen (PSA) for prostate cancer (PCa) screening led to overinvestigation and overdiagnosis of indolent PCa. We aimed to investigate the value of prostate health index (PHI) a...
Metastatic prostate cancer (mPCa) patients complicated with bladder outlet obstruction (BOO) are often referred to a urologist. Androgen deprivation therapy (ADT) combined with indwelling catheter usu...
Although prostate-specific membrane antigen (PSMA) PET/CT has been shown valuable for staging biopsy-proven [B(+)] high-risk prostate cancer, elderly patients are occasionally referred for PSMA PET/CT...
Prostate MRI is now established as a first-line investigation for individuals presenting with suspected localized or locally advanced prostate cancer. Successful delivery of the MRI-directed pathway f...
Prostate cancer has a long disease history and a wide variety and uncertainty in individual patients' clinical progress. In recent years, we have seen a revolutionary advance in both prostate cancer p...
There is a clinical need to identify patients with an elevated PSA who would benefit from prostate biopsy due to the presence of clinically significant prostate cancer (CSCaP). We have previously repo...
To further develop and adapt the MiCheck® Prostate test so it can be performed using a standard clinical chemistry analyzer and characterize its performance using the MiCheck-01 clinical trial sample ...
About 358 patient samples from the MiCheck-01 US clinical trial were used for the development of the MiCheck® Prostate test. These consisted of 46 controls, 137 non-CaP, 62 non-CSCaP, and 113 CSCaP....
Serum analyte concentrations for cellular growth factors were determined using custom-made Luminex-based R&D Systems multi-analyte kits. Analytes that can also be measured using standard chemistry ana...
Logistic regression modeling with Monte Carlo cross-validation was used to identify Human Epidydimal Protein 4 (HE4) as an analyte able to significantly improve the algorithm specificity at 95% sensit...
The MiCheck® logistic regression model was developed and consisted of PSA, %free PSA, DRE, and HE4. The model differentiated clinically significant cancer from no cancer or not-clinically significant ...
The MiCheck® Prostate test identifies clinically significant prostate cancer with high sensitivity and negative predictive value (NPV). It can be performed in a clinical laboratory using a Roche Cobas...
Prostate health index (PHI) and, more recently, Proclarix have been proposed as serum biomarkers for prostate cancer (PCa). In this study, we aimed to evaluate Proclarix and PHI for predicting clinica...
Proclarix and PHI were measured using samples of 344 men from two different centers. All patients underwent prostate biopsy, and among those, 188 men with PCa on biopsy had an additional radical prost...
The cohort median age and PSA were 65 (interquartile range [IQR]: 60-71) and 5.6 (IQR: 4.3-7.2) ng/ml, respectively. CsPCa was diagnosed in 161 (47%) men based on the RP specimen. ROC analysis showed ...
Results of this study show that both Proclarix and PHI accurately detect the presence of csPCa. The model combining Proclarix and PHI revealed the synergistic effect and improved the diagnostic perfor...
Transperineal (TP) multiparametric magnetic resonance imaging (mpMRI)-targeted biopsy (TBx) has been shown to detect more clinically significant (cs) prostate cancer (PCa) than standard template biops...
We identified all men who with suspicious lesions on mpMRI and underwent TP TBx (3-core) and concomitant SBx (20-core) in our single hospital from September 2019 to February 2021. Clinical, MRI and bi...
Three hundred and one (n = 301) men were included. The median prostate volume by MRI was 45 ml. The patients were divided by prostate volume into three groups: ≤30ml group (19.9%), >30 to ≤45 ml group...
Our data suggest that performing TBx with limited additional cores may potentially achieve the same csPCa detection rate as the combined SBx and TBx in smaller prostates....
We sought to determine whether two soluble forms with different size of mtDNA are linked to prostatic inflammation, and whether they discriminate prostate cancer (PCa) from inflammatory prostatic cond...
Histopathologically diagnosed prostatitis, PCa and benign prostatic hyperplasia patients (n = 93) were enrolled in this study and they were categorized as with and without prostate inflammation. Quant...
The urine mtDNA-79 and mtDNA-230 were significantly increased in patients with prostate inflammation compared with those in without inflammation. Here, 79-bp fragment of apoptotic origin was significa...
Our results demonstrate that shorter cf-mtDNA fragment size in particular, increase in the presence of prostate inflammation in post-prostatic massage urine but both fragments could never improve seru...